BenoitG., DelmasV., GillotC., JardinA.: The anatomy of erection. Surg. Radiol. Anat., 9; 263–272 (1987).
2.
EarleC.M., KeoghE.J., WisniewskiZ.S., TullochA.G.S., LordD.J., WattersG.R., GlatthaarC.: Prostaglandin E1 therapy for impotence, comparison with papaverine. J. Urol., W; 57–59 (1990).
3.
GolubM., ZiaP., MatsunoM., HortonH.: Metabolism of prostaglandin A1 and E1 in man. J. Clin. Invest., 56; 1404–1410 (1975).
4.
HedlundH.AnderssonK.E.: Contraction and relaxation induced by some prostanoids in isolated human penile erectile tissue and cavernous artery. J. Urol., 134; 1245–1250 (1985).
5.
I-ShengT.H., Chi-ReiY., Shyh-YenW., Chi-ZungC., Tzone-ShinT., Chao-HsiangC., Hsi-ChinW.: Impotence evaluated by the use of Prostaglandin E1. J. Urol., 141; 1357–1367 (1989).
6.
IshiiN.WatanabeH., IrisawaM., KikuchiY., KawamuraS., SuzukiK., ChibaR., TokiwaM., ShiraiM.: Studies on male sexual impotence. Report 18. Therapeutic trial with Prostaglandin E1 for organic impotence. Jap. J. Urol., 77; 954 (1986).
7.
IshiiN., WatanabeH., IrisawaC.: Intracavernous injection of Prostaglandin E1 for the treatment of erectile impotence. J. Urol., 141; 323–325 (1988).
8.
JeremyJ.Y., MikhailidisD.P., DandonaP.: Effects of Prostaglandin E1 on penile erection and erectile failure. J. Urol., 140; 136 (1989).
9.
JunemannK.P., JunemannC.P., AikenP.: Pathophysiology of erectile dysfunction. Seminars in Urology, 8; 83–90 (1988).
10.
LeeL.M., StevensonR.W.D., SzaszG.: Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison. J. Urol., 141; 549–550 (1989).
11.
LueT.F.: Intracavernous drug administration: its role in diagnosis and treatment of impotence. Seminars in Urology, 10; 100–106 (1990).
12.
QuadracciaA., CastellaniR.: Prima esperienza italiana nell'uso della PGE1 nel deficit erigendi. Acta Urol. Ital., 3; 299–302 (1989).
13.
SarosdyM.F., HudnallC.H., EricksonD.H., HardinT.C., NovickiD.E.: A prospective double-blind trial of intracorporeal papaverine versus Prostaglandine E1 in the treatment of impotence. J. Urol., 141; 551–553 (1989).
14.
SchramekP., DorimingerR., WaldhauserM., KonencnyP., PorpaczyP.: Prostaglandine E1 in erectile dysfunction. Efficiency and incidence of priapism. Brit. J. Urol., 65; 68–71 (1990).